In a left heart failure-related pulmonary hypertension rat model treated with ketotifen (mast cell stabilizer) and a WS/WS rat model with mast cell deficiency (due to the mutation of mast cell growth factor receptor c-kit), the symptoms and vascular remodeling of pulmonary hypertension were significantly reduced. This evidence concerns the gene KIT and pulmonary hypertension.